BFG
DXCM icon

Bleakley Financial Group’s DexCom DXCM Stock Holding History

Bleakley Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,685
Closed -$988K – 687
2025
Q3 		$988K Sell
14,685
-5,633
-28% -$446K 0.02% 422
2025
Q2 		$1.77M Buy
+20,318
New +$1.59M 0.05% 293
2025
Q1 		– Sell
-4,968
Closed -$386K – 642
2024
Q4 		$386K Sell
4,968
-322
-6% -$23.8K 0.01% 696
2024
Q3 		$355K Sell
5,290
-1,903
-26% -$156K 0.01% 709
2024
Q2 		$816K Buy
7,193
+337
+5% +$42.6K 0.02% 467
2024
Q1 		$951K Buy
6,856
+87
+1% +$10.9K 0.03% 441
2023
Q4 		$840K Sell
6,769
-8,496
-56% -$868K 0.03% 442
2023
Q3 		$1.42M Sell
15,265
-1,604
-10% -$181K 0.05% 320
2023
Q2 		$2.17M Sell
16,869
-1,005
-6% -$122K 0.07% 254
2023
Q1 		$2.08M Sell
17,874
-8,973
-33% -$1M 0.07% 246
2022
Q4 		$3.04M Buy
+26,847
New +$2.95M 0.11% 176

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bleakley Financial Group's DXCM Position: Q4 2025 in Review

Bleakley Financial Group sold out of DexCom (DXCM) in Q4 2025, closing a stake of 14,685 shares — an estimated $988K sold.

Bleakley Financial Group first reported a position in DXCM in Q4 2022 and held it in 11 quarters. The position peaked at $3.04M in Q4 2022. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Bleakley Financial Group reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 14,685 DexCom shares in Q4 2025, an estimated $988K.
  • Bleakley Financial Group first reported a position in DexCom in Q4 2022 and held it in 11 quarters.
  • Bleakley Financial Group's DexCom position peaked at $3.04M in Q4 2022.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Bleakley Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.